Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study

E-ISSN： 1097-0142|121|14|2411-2421

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.14, 2015-07, pp. : 2411-2421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-1 Receptor Antagonist Polymorphism in Patients with Prostate Cancer and Benign Prostatic Hyperplasia: A Case Control Study from North India

By Mittal R.D. Mishra D.K. Bid H.K. Mandhani A.

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 131-134

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cancer Gene Therapy Utilizing Interleukin-13 Receptor 2 Chain

Current Gene Therapy, Vol. 5, Iss. 2, 2005-04 ,pp. : 213-223

Bentham Science Publishers

Access to resources Recommend Favorite

New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate Cancer

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 290-302

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets for Metastatic Prostate Cancer

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 251-261

Bentham Science Publishers

Access to resources Recommend Favorite